Specification sheet
IGF-1 LR3
- Molecular weight
- 9117.6g/mol
- Formula
- C400H625N111O115S9
- CAS number
- 946870-92-4
Sequence
83 aa - IGF-1(1-70), Arg3 substitution, 13-residue N-terminal extension
- Type
- Synthetic peptide
- Form
- Lyophilized powder
- Sizes
- 1mg
Research access
Lumen supplies research compounds to qualified researchers and laboratories for in-vitro use. Confirm once to enter.
By entering you affirm the statement above is true. Products are not for human or veterinary use, not for diagnostic procedures, and have not been evaluated by the FDA.
99.75%HPLC purity
Secretagogue Research
Long-acting IGF-1 analog studied for anabolic and repair signaling.
$90.001mg vial
Buy 1, get 1 free: add a 2nd vial and it is free.
Researchers also added
Mix and match: Buy 1, get 1 free pairs any two vials in your cart. Research use only.
The compound
IGF-1 LR3 is an 83-residue analog of insulin-like growth factor 1 carrying an arginine substitution at position 3 and an N-terminal extension. Both modifications reduce binding to IGF-binding proteins, which is why it is favoured as a longer-acting reference agonist in cell-culture work. Research use only.
Specification sheet
Sequence
83 aa - IGF-1(1-70), Arg3 substitution, 13-residue N-terminal extension
Where it is studied
Agonism at IGF-1R is studied for downstream PI3K/Akt and MAPK signaling in proliferation models.
The LR3 modifications lower binding-protein affinity, extending free availability in culture.
Investigated in myotube and cell-survival models. Not a human efficacy claim.
In the lab
IGF-1 LR3 is IGF-I with Arg in place of Glu3 plus a 13-residue N-terminal extension, and it binds IGF-binding proteins at least 1000-fold more weakly. In laboratory research it raised Akt signaling in mammary tissue and nitric-oxide-dependent artery responses.

Compound
IGF-1 LR3Arg3 IGF-I with a 13-residue N-terminal extensionMammary arteries
Endpoint studied
Less constrictionShifted noradrenaline constriction in isolated arteries; lost without endothelium or with NOS blocked.Gow 2000 · PMID 10825414 (opens PubMed in a new tab)Mammary tissue
Endpoint studied
Lactation capacityRaised phospho-Akt and SOCS3 gene expression in mammary tissue, with a modest rise in lactation capacity.Hadsell 2008 · PMID 18577570 (opens PubMed in a new tab)Preimplantation embryos
Endpoint studied
More blastocyst cellsMost cells per blastocyst; IGF-I-R mRNA rose 1.3-fold and IGFBP-2 mRNA 2.8-fold vs control.Prelle 2001 · PMID 11181549 (opens PubMed in a new tab)Research history
5 milestones, each linked to its PubMed record.
1993
The Journal of Endocrinology
LR3IGF-I, a potent analog with markedly reduced IGFBP binding, circulates mostly as free peptide and clears faster than IGF-I.
PubMed · PMID 7693845 (opens in a new tab)1997
The American Journal of Physiology
Enlarged gut, kidney and spleen in a developing gut model; LR3IGF-I was more potent than IGF-I.
PubMed · PMID 9124573 (opens in a new tab)1999
The Journal of Biological Chemistry
Mass spectrometry traps three disulfide folding intermediates of LR3IGF-I, which carries Arg3 and a 13-residue extension.
PubMed · PMID 10608814 (opens in a new tab)2000
Experimental Physiology
Isolated mammary arteries constrict less to noradrenaline, an effect that needs endothelium and nitric oxide synthesis.
PubMed · PMID 10825414 (opens in a new tab)2025
Journal of Alzheimer's Disease
Shifted cortical plaques toward inert forms in an amyloid model but did not preserve memory.
PubMed · PMID 39610283 (opens in a new tab)Laboratory research only, cited for research context. Not a claim about use in people.
Catalog peptides are specified at 99%+ identity purity. Each lot is verified by an independent laboratory using HPLC and mass spectrometry, and the results are published in that lot's Certificate of Analysis.
A COA is the lab document issued for a specific production lot. It records the compound's identity confirmation, measured purity and the lot number, so the vial on the bench can be traced back to its test results.
Orders placed before the daily cutoff ship the same or next business day from a US facility. Lyophilized peptides are stable in transit and do not require cold shipping.
L-H2O is a sterile, USP-grade laboratory solvent containing 0.9% benzyl alcohol. It is a bench accessory, not a peptide, and carries no HPLC purity claim or COA.
Research use only. Sold strictly for in-vitro laboratory research by qualified professionals. Not for human or veterinary use, not for diagnostic or therapeutic procedures, and not evaluated by the FDA.